Charles Schwab
ACLX

Charles Schwab’s Arcellx ACLX Stock Holding History

Charles Schwab’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39.7M Buy
346,092
+6,279
+2% +$554K 0.01% 1300
2025
Q4 		$22.2M Buy
339,813
+9,327
+3% +$744K ﹤0.01% 1684
2025
Q3 		$27.1M Buy
330,486
+11,214
+4% +$807K ﹤0.01% 1552
2025
Q2 		$21M Sell
319,272
-17,677
-5% -$1.1M ﹤0.01% 1645
2025
Q1 		$22.1M Sell
336,949
-6,136
-2% -$416K ﹤0.01% 1589
2024
Q4 		$26.3M Buy
343,085
+14,992
+5% +$1.3M ﹤0.01% 1546
2024
Q3 		$27.4M Buy
328,093
+14,200
+5% +$946K 0.01% 1520
2024
Q2 		$17.3M Buy
313,893
+31,883
+11% +$1.73M ﹤0.01% 1766
2024
Q1 		$19.6M Buy
282,010
+17,832
+7% +$1.13M ﹤0.01% 1624
2023
Q4 		$14.7M Buy
264,178
+3,722
+1% +$168K ﹤0.01% 1782
2023
Q3 		$9.35M Buy
260,456
+19,518
+8% +$673K ﹤0.01% 1942
2023
Q2 		$7.62M Buy
240,938
+33,687
+16% +$1.29M ﹤0.01% 2037
2023
Q1 		$6.39M Sell
207,251
-423
-0.2% -$12.8K ﹤0.01% 2093
2022
Q4 		$6.43M Buy
207,674
+4,835
+2% +$111K ﹤0.01% 2076
2022
Q3 		$3.81M Buy
202,839
+136,937
+208% +$2.62M ﹤0.01% 2365
2022
Q2 		$1.19M Sell
65,902
-761
-1% -$9.82K ﹤0.01% 2728
2022
Q1 		$935K Buy
+66,663
New +$1.11M ﹤0.01% 2879

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Charles Schwab's ACLX Position: Q1 2026 in Review

Charles Schwab increased its Arcellx (ACLX) stake by 1.8% in Q1 2026, buying an estimated $554K and bringing the position to 346,092 shares worth $39.7M. The position accounts for 0.01% of the portfolio, ranked #1300.

Charles Schwab first reported a position in ACLX in Q1 2022 and has held it in 17 quarters since. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • Charles Schwab held 346,092 shares of Arcellx worth $39.7M as of Q1 2026.
  • Charles Schwab bought 6,279 Arcellx shares in Q1 2026, an estimated $554K.
  • Arcellx made up 0.01% of Charles Schwab's portfolio in Q1 2026, its #1300 holding.
  • Charles Schwab first reported a position in Arcellx in Q1 2022 and has held it in 17 quarters since.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.